clinic
sign
symptom
associ
mani
infecti
diseas
often
nonspecif
discrimin
caus
agent
thu
definit
diagnosi
requir
specif
laboratori
test
suspect
pathogen
particular
respiratori
tract
infect
caus
numer
differ
viral
bacteri
fungal
pathogen
indistinguish
clinic
diagnosi
respiratori
tract
infect
also
among
common
infect
human
approxim
episod
per
year
children
episod
per
year
adult
infect
caus
consider
morbid
mortal
well
high
healthcar
cost
associ
doctor
visit
hospit
treatment
absenc
work
school
earli
diagnosi
etiolog
agent
respiratori
infect
permit
effect
antimicrobi
therapi
appropri
manag
diseas
molecular
assay
design
directli
detect
microbi
nucleic
acid
sequenc
patient
specimen
allow
rapid
diagnosi
treatment
infecti
diseas
high
accuraci
reduc
turnaround
time
compar
tradit
immunolog
culturebas
method
molecular
test
methodolog
permit
multiplex
advantag
allow
simultan
detect
multipl
nucleic
acid
sequenc
sampl
singl
reaction
vessel
multiplex
test
reduc
time
labor
cost
laboratori
test
compar
singl
reaction
detect
method
addit
improv
effici
also
higher
diagnost
yield
abil
detect
multipl
infect
thu
multiplex
molecular
assay
effici
method
definit
diagnosi
respiratori
infect
also
provid
inform
coinfect
secondari
infect
among
variou
multiplex
technolog
avail
microspher
beadbas
suspens
array
emerg
standard
molecular
multiplex
technolog
clinic
microbiolog
laboratori
compar
planar
array
benefit
beadbas
array
includ
eas
use
low
cost
statist
superior
excel
sensit
specif
faster
hybrid
kinet
flexibl
array
prepar
rapid
data
acquisit
technolog
platform
first
commerci
beadbas
array
platform
use
differenti
dy
microspher
size
achiev
multianalyt
profil
protein
nucleic
acid
key
driver
adopt
xmap
platform
includ
cost
save
labor
workflow
effici
sampl
conserv
high
sensit
broad
dynam
rang
system
ad
benefit
open
platform
assay
rapidli
develop
optim
implement
end
user
versatil
open
architectur
evidenc
approxim
peerreview
public
describ
varieti
applic
result
platform
rapidli
adopt
nucleic
acid
protein
analysi
variou
laboratori
set
system
achiev
k
clearanc
statu
vitro
diagnost
ivd
applic
breadth
bioanalyt
applic
platform
includ
hundr
commerci
avail
analyt
vast
number
custom
assay
develop
global
instal
base
instrument
chapter
describ
principl
use
xmap
technolog
platform
infecti
diseas
nucleic
acid
detect
emphasi
applic
detect
identif
respiratori
virus
luminex
xmap
system
incorpor
polystyren
microspher
bead
intern
dy
two
three
spectral
distinct
fluorochrom
use
precis
amount
fluorochrom
array
creat
consist
differ
bead
set
specif
spectral
address
uniqu
spectral
characterist
within
individu
bead
set
allow
bead
region
specif
differenti
other
multiplex
bead
set
possess
differ
reactant
surfac
bead
set
distinguish
spectral
address
address
associ
specif
analyt
target
combin
singl
reaction
measur
differ
analyt
simultan
addit
fluorochrom
coupl
report
molecul
quantifi
biomolecular
interact
occur
bead
surfac
configur
xmap
nucleic
assay
consist
suspens
array
specif
captur
oligonucleotid
coval
coupl
surfac
intern
dy
bead
set
complet
assay
incub
nucleic
acid
sampl
detect
report
reagent
reaction
analyz
within
luminex
reader
classifi
bead
base
spectral
address
bead
ident
region
quantifi
bound
fluorophor
report
detect
channel
potenti
simultan
detect
protein
nucleic
acid
target
provid
rapid
sensit
specif
multiplex
molecular
analys
first
gener
xmap
microspher
util
two
intern
fluoresc
dye
produc
array
spectral
distinct
bead
set
inclus
third
intern
dye
allow
expans
origin
bead
region
fig
sever
varieti
fluoresc
bead
reagent
avail
luminex
fundament
microspher
polystyren
bead
function
surfac
carboxyl
group
coval
attach
captur
ligand
current
avail
xmap
assay
develop
microplex
microspher
microspher
superparamagnet
bead
function
surfac
carboxyl
group
coval
attach
ligand
magplex
microspher
exhibit
high
perform
low
nonspecif
bind
magnet
separ
solut
allow
easi
autom
assay
process
simplifi
assay
wash
step
microspher
reagent
precoupl
uniqu
captur
oligonucleotid
oligo
also
avail
nucleic
acid
assay
develop
reagent
incorpor
use
technolog
proprietari
univers
tag
sort
system
allow
easi
optim
develop
expans
molecular
diagnost
assay
elimin
need
coupl
contentspecif
captur
probe
bead
xtag
oligo
optim
isotherm
set
minimum
crossreact
earlier
assay
use
microspher
nonmagnet
microplex
bead
contain
two
intern
fluoresc
dye
precoupl
xtag
oligo
captur
sequenc
antitag
bead
replac
microspher
superparamagnet
magplex
bead
contain
two
three
intern
fluoresc
dye
precoupl
antitag
captur
oligo
current
three
xmap
analyz
avail
luminex
partner
luminex
flexmap
fig
luminex
flexmap
flow
analyz
capabl
multiplex
respect
fluidic
laserbas
optic
similar
tradit
flow
cytometri
instrument
magpix
util
flow
cell
ccdbase
optic
magnet
bead
multiplex
flow
analyz
bead
introduc
rapidli
flow
fluid
stream
hydrodynam
focus
interrog
individu
pass
two
separ
laser
red
diod
laser
excit
fluorochrom
contain
within
microspher
yttrium
aluminum
garnet
yag
laser
excit
report
fluorochrom
rphycoerythrin
alexa
bound
bead
surfac
highspe
digit
signal
process
classifi
microspher
base
spectral
address
quantifi
reaction
microspher
surfac
multipl
read
made
per
microspher
set
provid
valid
robust
statist
thousand
microspher
interrog
per
second
result
system
capabl
analyz
report
differ
reaction
singl
reaction
vessel
second
per
sampl
luminex
design
meet
multiplex
test
need
clinic
research
laboratori
built
proven
exist
technolog
includ
flow
cytometri
microspher
laser
digit
signal
process
tradit
chemistri
luminex
analyz
allow
multiplex
analysi
analyt
per
reaction
system
versatil
use
varieti
applic
immunoassay
genotyp
gene
express
enzymat
assay
microlit
sampl
reaction
provid
result
thu
platform
well
suit
applic
sampl
size
limit
robust
optic
fluidic
afford
quantit
result
log
dynam
rang
strong
concord
enzymelink
immunosorb
assay
elisa
realtim
polymeras
chain
reaction
pcr
mass
spectrometri
intuit
templatebas
softwar
oper
system
design
use
commerci
kit
custom
protocol
simpl
assay
set
plate
read
data
analysi
capabl
cfr
part
compat
upgrad
offer
multilevel
user
manag
full
audit
trail
electron
record
electron
signatur
system
approv
ivd
use
xmapbas
k
clear
kit
avail
numer
exist
laboratorydevelop
test
ldt
flexmap
enhanc
flowbas
multiplex
system
util
xmap
technolog
flexmap
system
assur
rapid
highthroughput
analys
without
compromis
flexibl
perform
optim
workflow
autom
routin
task
integr
frontend
sampl
prepar
platform
enhanc
optic
permit
multiplex
analyt
per
well
provid
enhanc
sensit
dynam
rang
extend
log
system
compat
plate
pierc
probe
allow
seal
plate
analyz
dual
syring
configur
process
plate
time
faster
luminex
system
softwar
xponent
autom
li
interfac
compon
includ
walkaway
mainten
calibr
function
combin
advanc
featur
capabl
help
acceler
discoveri
develop
process
make
flexmap
ideal
platform
multiplex
analyt
may
broadli
dissimilar
level
elimin
need
sampl
reanalysi
due
outofrang
result
magpix
util
flow
cell
robust
ledccdbas
optic
releas
juli
magpix
system
support
multiplex
test
singl
reaction
volum
use
magplex
magplextag
bead
magpix
react
magnet
bead
sent
flow
cell
imag
flow
cell
magnet
actuat
pull
bead
suspens
hold
place
optic
analysi
red
led
excit
fluoresc
dye
contain
within
microspher
green
led
excit
report
fluorochrom
bound
bead
surfac
ccd
imag
identifi
bead
region
quantifi
bound
report
xponent
magpix
oper
system
use
commerci
kit
userdevelop
assay
lower
cost
compact
size
requir
cm
bench
space
magpix
provid
afford
multiplex
solut
ideal
low
mediumthroughput
laboratori
remot
laboratori
test
site
captur
oligo
modifi
spacer
termin
amin
eg
coval
coupl
carboxyl
bead
use
carbodiimid
coupl
procedur
captur
oligo
resuspend
dilut
tri
azid
aminecontain
buffer
interfer
coupl
process
oligo
previous
solubil
aminecontain
buffer
desalt
column
precipit
resuspend
stock
uncoupl
carboxyl
bead
wash
resuspend
mm
nmorpholino
ethanesulfon
acid
me
ph
captur
oligo
ad
follow
addit
n
edc
incub
dark
min
edc
addit
incub
repeat
coupl
bead
wash
sd
coupl
microspher
store
mm
mm
edta
ph
te
dark
properli
store
coupl
microspher
usual
stabl
year
coupl
reaction
easili
scale
accord
user
need
initi
coupl
optim
coupl
amount
ie
nmol
oligo
per
million
microspher
usual
done
small
coupl
reaction
million
microspher
coupl
reaction
scale
manufactur
prepar
bulk
reagent
optim
coupl
effici
import
perform
oligo
coupl
reaction
small
reaction
volum
possibl
typic
million
bead
verif
coupl
perform
use
biotinyl
revers
complementari
posit
control
oligo
coupl
microspher
resuspend
vortex
sonic
combin
final
concentr
bead
hybrid
buffer
target
biotinyl
oligo
ad
fmol
hybrid
coupl
bead
min
follow
label
report
streptavidinrphycoerythrin
min
reaction
readi
analysi
effect
coupl
demonstr
dose
respons
increas
median
fluoresc
intens
mfi
increas
concentr
oligo
target
sever
assay
chemistri
use
nucleic
acid
detect
xmap
system
one
approach
use
direct
hybrid
label
pcramplifi
target
dna
bead
set
bear
oligonucleotid
captur
probe
specif
sequenc
fig
direct
hybrid
simplest
assay
chemistri
provid
singl
nucleotid
discrimin
take
advantag
fact
melt
temperatur
hybrid
perfectli
match
templat
compar
one
singl
base
mismatch
differ
sever
degre
captur
oligo
approxim
nucleotid
length
reaction
kinet
advers
affect
immobil
reactant
solid
surfac
effect
less
sever
beadbas
suspens
array
howev
diffus
rate
immobil
captur
probe
slower
effect
concentr
reduc
compar
free
dna
solut
design
sequencespecif
captur
probe
pcr
primer
direct
hybrid
assay
xmap
suspens
array
facilit
use
tetramethylammonium
chlorid
tmac
contain
hybrid
buffer
tmac
stabil
base
pair
minim
effect
base
composit
hybrid
oligo
less
base
pair
length
hybrid
effici
tmac
function
length
perfect
match
less
depend
base
composit
thu
hybrid
buffer
incorpor
tmac
equal
melt
point
differ
probe
allow
probe
differ
characterist
use
ident
condit
high
duplex
yield
typic
singl
nucleotid
discrimin
captur
probe
design
match
length
approxim
nucleotid
probe
complementari
sequenc
label
strand
pcr
product
polymorph
nucleotid
locat
center
probe
mismatch
center
profound
effect
equilibrium
state
mismatch
near
optim
assay
condit
determin
evalu
effect
hybrid
temperatur
probe
length
input
target
concentr
assay
sensit
specif
probe
melt
temperatur
influenc
length
sequenc
type
posit
mismatch
base
effect
mismatch
hybrid
greater
increas
temperatur
decreas
probe
length
thu
discrimin
improv
increas
hybrid
temperatur
andor
decreas
probe
length
test
known
dna
sampl
set
standard
hybrid
condit
nucleotid
ad
andor
end
probe
improv
sensit
remov
andor
end
probe
increas
specif
posit
polymorph
within
probe
sequenc
adjust
necessari
avoid
format
secondari
structur
adequ
specif
usual
achiev
polymorph
nucleotid
posit
probe
pcr
primer
typic
design
amplifi
base
pair
region
target
sequenc
one
primer
pair
biotinyl
end
label
target
strand
amplicon
use
small
target
dna
minim
potenti
steric
hindranc
affect
hybrid
effici
case
larger
target
base
pair
use
success
suggest
hybrid
effici
also
depend
sequenc
overal
secondari
structur
target
hybrid
kinet
thermodynam
affin
match
mismatch
sequenc
driven
concentrationdepend
manner
concentr
beyond
satur
level
hybrid
effici
decreas
presum
due
competit
complementari
strand
renatur
pcr
product
therefor
also
import
determin
rang
target
concentr
yield
effici
hybrid
without
sacrif
discrimin
anoth
approach
use
sequencespecif
enzymat
reaction
solut
determin
target
sequenc
follow
captur
onto
bead
surfac
detect
fig
format
involv
incorpor
specif
captur
sequenc
enzymat
step
allow
hybrid
complementari
address
sequenc
bead
surfac
commonli
use
enzymat
method
sequenc
determin
reli
discrimin
abil
dna
polymeras
dna
ligas
includ
allelespecif
targetspecif
primer
extens
asp
tspe
oligonucleotid
ligat
assay
ola
singl
base
chain
extens
sbce
targetspecif
pcr
tspcr
approach
take
advantag
solutionphas
kinet
permit
address
bead
set
use
mani
differ
assay
new
sequenc
target
ad
appropri
captur
sequenc
targetspecif
oligo
use
enzymat
step
hybrid
buffer
reaction
condit
detect
depend
upon
captur
sequenc
attach
microspher
commerci
avail
luminex
magplextag
microspher
precoupl
xtag
captur
oligo
antitag
compat
solutionbas
enzymat
chemistri
assay
develop
append
appropri
complementari
tag
sequenc
targetspecif
oligo
allow
captur
onto
correspond
antitag
coupl
bead
assay
develop
paramet
enzymat
solutionbas
nucleic
acid
assay
xmap
platform
describ
variou
procedur
illustr
fig
briefli
targetspecif
oligo
design
match
melt
temperatur
tspe
tspcr
ola
discrimin
nucleotid
posit
end
oligo
wherea
sbce
end
primer
posit
one
nucleotid
upstream
uniqu
captur
sequenc
target
incorpor
end
oligo
optim
need
improv
sensit
specif
achiev
ad
remov
nucleotid
end
targetspecif
sequenc
immedi
downstream
captur
sequenc
target
opposit
dna
strand
templat
contain
target
sequenc
tspe
ola
sbce
reaction
gener
pcr
use
unlabel
primer
tspe
thermost
polymeras
use
extend
primer
incorpor
dntp
includ
one
biotinlabel
extens
occur
nucleotid
primer
complementari
anneal
templat
dna
ola
employ
oligo
design
thermost
ligas
use
ligat
biotinlabel
oligo
report
probe
complementari
sequenc
downstream
target
nucleotid
report
probe
design
match
melt
temperatur
phosphoryl
end
provid
substrat
ligas
biotinlabel
end
fluoresc
detect
streptavidinrphycoerythrin
sbce
individu
reaction
must
set
four
possibl
nucleotid
thermost
polymeras
use
incorpor
singl
biotinlabel
ddntp
extens
occur
nucleotid
complementari
sequenc
immedi
downstream
primer
present
reaction
target
sbce
combin
nucleotid
reaction
differ
captur
sequenc
use
product
multiplex
captur
onto
address
microspher
set
tspcr
target
sequenc
directli
amplifi
label
pcr
use
one
primer
contain
captur
targetspecif
sequenc
pair
biotinyl
targetspecif
primer
method
requir
strategi
minim
elimin
product
captur
sequenc
nontarget
strand
would
compet
hybrid
target
address
bead
method
includ
asymmetr
pcr
postpcr
treatment
phosphatas
exonucleas
incorpor
spacer
capturespecif
targetspecif
sequenc
primer
tspcr
chemistri
elimin
need
separ
amplif
targetspecif
enzymat
step
thu
simplifi
assay
procedur
reduc
reagent
cost
turnaround
time
molecular
analysi
infecti
organ
wide
appli
healthcar
numer
applic
use
xmap
technolog
describ
detect
bacteri
viral
fungal
parasit
pathogen
sever
commerci
product
avail
multiplex
detect
identif
respiratori
virus
use
xmap
beadbas
suspens
array
includ
ii
panel
qiagen
inc
valencia
ca
xtag
rvp
xtag
rvp
fast
assay
luminex
molecular
diagnost
inc
toronto
sinc
develop
assay
increasingli
use
clinic
diagnost
epidemiolog
research
numer
studi
util
beadbas
suspens
array
assay
respiratori
viru
detect
report
resplex
ii
panel
research
use
ruo
product
employ
novel
multiplex
revers
transcriptionpolymeras
chain
reaction
rtpcr
strategi
call
tempcr
target
enrich
multiplexingpcr
combin
direct
hybrid
captur
onto
targetspecif
probecoupl
bead
set
tempcr
use
nest
genespecif
primer
low
concentr
enrich
specif
target
initi
pcr
cycl
follow
univers
forward
revers
primer
high
unequ
concentr
achiev
exponenti
asymmetr
amplif
primer
excess
biotinyl
yield
surplu
label
target
strand
hybrid
detect
complementari
bead
set
resplex
ii
panel
detect
respiratori
viral
target
respiratori
syncyti
virus
rsv
b
influenza
viru
flua
influenza
b
viru
flub
parainfluenza
virus
piv
human
metapneumovirus
hmpv
b
coxsackievirusesechoviru
cvev
rhinoviru
rhv
adenovirus
adv
e
coronavirus
cov
bocaviru
bocv
panel
also
includ
intern
control
monitor
viral
rna
isol
pcr
inhibit
posit
control
human
genom
dna
monitor
sampl
integr
success
run
li
et
al
evalu
resplex
ii
panel
retrospect
studi
use
frozen
respiratori
specimen
result
compar
obtain
refer
standard
cultur
individu
realtim
rtpcr
assay
sensit
specif
flua
flub
rsv
respect
assay
could
process
sampl
h
brunstein
et
al
use
resplex
ii
panel
combin
resplex
assay
test
bacteri
pathogen
adv
e
parallel
dfa
cultur
test
protocol
investig
incid
coinfect
potenti
complex
interact
multipl
pathogen
respiratori
infect
coinfect
found
specimen
test
use
multipl
statist
method
determin
pattern
associ
pathogen
found
individu
specimen
potenti
posit
correl
found
specimen
coinfect
follow
streptococcu
pneumonia
haemophilu
influenza
neisseria
meningitidi
flub
cvev
rhv
addit
overal
preval
pneumonia
preval
rsv
b
posit
specimen
although
result
preliminari
author
conclud
data
support
hypothesi
coinfect
multipl
respiratori
pathogen
medic
relev
effect
treatment
sever
respiratori
infect
may
requir
diagnosi
pathogen
involv
rather
singlepathogen
report
protocol
diagnost
test
discontinu
identif
first
relev
pathogen
xtag
respiratori
viral
panel
rvp
assay
util
tspe
chemistri
xtag
technolog
identifi
major
respiratori
virus
commonli
encount
includ
flua
subtyp
singl
test
assay
approv
vitro
diagnost
use
ivd
unit
state
canada
europ
viru
type
subtyp
depend
geograph
locat
regulatori
clearanc
statu
target
region
shown
tabl
assay
also
includ
intern
extract
control
posit
run
control
xtag
data
analysi
softwar
tda
interpret
mfi
result
establish
presenc
absenc
target
rvp
compat
luminex
instrument
provid
result
sampl
singl
work
day
approxim
h
rvp
assay
first
describ
mahoni
et
al
prospect
evalu
use
nasopharyng
swab
np
specimen
compar
direct
fluoresc
antibodi
assay
dfa
cultur
rvp
detect
posit
compar
posit
detect
dfacultur
sensit
detect
addit
posit
specimen
either
neg
dfacultur
posit
virus
test
dfacultur
follow
resolut
discord
pcr
rvp
detect
true
posit
sensit
compar
true
posit
dfacultur
sensit
rvp
detect
presenc
two
virus
specimen
test
perform
rvp
also
compar
realtim
pcr
parallel
studi
use
sampl
extract
result
compar
sampl
ct
valu
less
equal
rvp
demonstr
signal
nois
ratio
greater
equal
ivd
clearanc
perform
characterist
rvp
assay
establish
multicent
clinic
trial
involv
six
site
north
america
europ
use
total
specimen
collect
test
influenza
season
prospect
collect
np
swab
sensit
greater
analyt
except
adv
howev
two
posit
specimen
avail
sequenc
analysi
reveal
low
overal
sensit
adv
mainli
due
poor
detect
serotyp
adv
c
speci
addit
posit
sampl
avail
cov
thu
sensit
cov
type
rang
could
determin
specif
greater
analyt
limit
detect
lod
median
tissu
cultur
infect
dose
ml
overal
sitetosit
reproduc
interfer
detect
combin
analyt
plu
potenti
bacteri
viral
interfer
crossreact
observ
bacteri
viral
pathogen
test
one
bocv
sampl
yield
fals
posit
call
rhv
subsequ
determin
contamin
rhv
addit
signific
differ
sensit
target
analyt
medic
versu
unmed
patient
comparison
studi
resplex
ii
rvp
suspens
array
assay
detect
virus
cultur
adult
respiratori
specimen
includ
np
swab
bronchoalveolar
lavag
bal
lung
biopsi
pleural
fluid
sputa
rvp
show
sensit
neg
predict
valu
npv
specif
near
perfect
agreement
cultur
resplex
ii
slightli
higher
specif
posit
predict
valu
ppv
sensit
coinfect
detect
sampl
includ
piv
furthermor
detect
multipl
infect
resplex
ii
easiest
use
one
reagent
preparationamplif
step
one
hybridizationdetect
step
gener
result
h
wherea
rvp
labor
intens
five
reagent
prepar
step
two
thermal
cycler
program
result
h
turnaround
time
resplex
ii
ruo
offer
broader
coverag
viru
type
rvp
ivd
assay
rvp
abil
differenti
human
nonhuman
flua
subtyp
author
conclud
compar
cultur
multiplex
molecular
assay
could
provid
enhanc
sensit
faster
turnaround
time
broader
coverag
prove
use
tool
respiratori
viru
identif
aid
patient
manag
outbreak
investig
multiplex
molecular
assay
use
screen
tool
detect
novel
emerg
viral
strain
outbreak
investig
wong
et
al
use
rvp
assay
retrospect
studi
specimen
suspect
respiratori
viru
outbreak
assess
util
enhanc
respiratori
outbreak
investig
use
combin
dfa
variou
inhous
nucleic
acid
amplif
test
nat
rvp
test
improv
detect
viral
etiolog
agent
outbreak
rvp
assay
also
prove
effect
aid
detect
strain
assay
detect
matrix
gene
identifi
hemagglutinin
ha
gene
clinic
specimen
new
york
outbreak
rvp
assay
use
test
sampl
initi
test
posit
flua
rapid
antigen
test
dfa
cultur
patient
suspect
infect
rvp
identifi
sampl
flua
identifi
season
strain
remain
unsubtyp
neg
cdc
realtim
rtpcr
assay
specif
use
test
specimen
identifi
posit
data
indic
predict
unsubtyp
flua
identifi
rvp
assay
pandem
high
implement
rvp
screen
test
algorithm
enabl
laboratori
rapidli
subtyp
flua
rule
season
subtyp
detect
addit
respiratori
virus
identifi
probabl
pandem
case
xtag
rvp
fast
assay
newer
version
xtag
rvp
assay
modifi
simpler
protocol
faster
turnaround
time
assay
approv
ivd
use
unit
state
canada
europ
viru
type
subtyp
tabl
target
detect
modifi
slightli
rvp
assay
depend
geograph
locat
addit
detect
bocv
rvp
fast
use
tspcr
chemistri
multiplex
rtpcr
reaction
perform
use
targetspecif
upstream
primer
contain
tag
captur
sequenc
pair
biotinyl
downstream
primer
amplifi
target
sequenc
singl
reaction
amplifi
product
ad
combin
hybridizationdetect
reaction
contain
correspond
antitag
bead
set
streptavidinrphycoerythrin
report
complet
reaction
read
luminex
analyz
determin
mfi
signal
raw
fluoresc
valu
analyz
use
tda
rvp
fast
softwar
target
interpret
present
absent
rvp
fast
assay
combin
amplif
targetspecif
extens
use
combin
hybrid
detect
step
result
turnaround
time
less
h
includ
nucleic
acid
extract
risk
contamin
postpcr
manipul
minim
reduct
oper
handl
step
singl
postpcr
transfer
perform
characterist
rvp
fast
ivd
use
determin
two
dataset
result
multicent
clinic
studi
total
specimen
eucanada
studi
np
swab
specimen
us
studi
submit
viral
test
three
independ
laboratori
combin
dataset
n
sensit
greater
analyt
except
piv
sensit
respect
specif
lod
rang
depend
analyt
addit
specimen
collect
test
subset
target
show
sensit
specif
compar
realtim
rtpcr
np
swab
dataset
n
sensit
specif
respect
coinfect
identifi
specimen
commonli
due
rsvrhv
preval
fluarhv
preval
lod
viral
analyt
target
determin
serial
dilut
high
titer
stock
univers
transport
medium
utm
rang
crossreact
observ
bacteri
viral
pathogen
test
interfer
detect
combin
analyt
plu
potenti
bacteri
viral
interfer
addit
signific
differ
sensit
target
analyt
medic
versu
unmed
patient
rvp
fast
compar
cultur
dfa
combin
singl
multiplex
realtim
rtpcr
assay
retrospect
studi
respiratori
specimen
least
one
respiratori
viru
detect
specimen
cultur
dfa
combin
realtim
rtpcr
rvp
fast
use
realtim
rtpcr
result
gold
standard
rvp
fast
sensit
specif
specimen
detect
rvp
fast
gener
low
viral
load
contain
adv
viral
target
posit
sampl
avail
set
test
suggest
studi
use
larger
number
posit
sampl
need
fulli
assess
sensit
rvp
fast
target
overal
investig
found
rvp
fast
rapid
easi
perform
comparison
multipl
realtim
rtpcr
assay
would
requir
equal
target
coverag
pabbaraju
et
al
compar
rvp
fast
origin
rvp
assay
respiratori
specimen
previous
character
varieti
respiratori
viru
target
sampl
test
parallel
assay
rvp
assay
found
sensit
rvp
fast
combin
target
sensit
respect
howev
rvp
fast
tenfold
sensit
detect
rsv
target
detect
rvp
fast
primarili
flub
cov
addit
small
number
sampl
posit
flua
rsv
b
hmnv
detect
rvp
assay
gener
low
viral
load
reproduc
similar
two
assay
rvp
fast
exhibit
better
reproduc
detect
adv
lod
author
conclud
rvp
fast
met
diagnost
need
sensit
specif
laboratori
except
flub
decreas
sensit
flub
specimen
collect
reduc
sensit
cov
lesser
concern
low
preval
detect
cov
affect
establish
patient
manag
protocol
preliminari
studi
also
indic
use
rvp
fast
lead
cost
save
improv
turnaround
time
result
shorter
protocol
reduct
handson
time
h
open
xmap
platform
lend
rapid
develop
new
assay
analyt
interest
identifi
describ
exampl
emerg
antivir
resist
influenza
rais
concern
use
antivir
drug
treatment
respons
futur
pandem
outbreak
amantadin
resist
increas
dramat
increas
oseltamivir
resist
season
report
worldwid
sinc
current
resist
test
done
sequenc
phenotyp
assay
costli
time
consum
howev
multiplex
beadbas
array
could
appli
purpos
combin
addit
comprehens
respiratori
viral
panel
illustr
report
multiplex
beadbas
ldt
develop
simultan
identif
flua
subtyp
oseltamivir
resist
genotyp
assay
employ
use
degener
primer
amplif
ha
neuraminidas
na
gene
eight
targetspecif
primer
tag
modif
tspe
subsequ
detect
microplexxtag
bead
assay
evalu
use
np
specimen
flua
posit
dfa
realtim
rtpcr
matrix
gene
capabl
correctli
identifi
flua
subtyp
oseltamivir
sensit
resist
allel
sampl
season
isol
identifi
pandem
isol
sensit
resist
reveal
combin
allel
assay
also
inexpens
run
combin
reagent
cost
canadian
dollar
cad
per
test
cost
analysi
studi
indic
use
multiplex
beadbas
array
diagnosi
respiratori
viral
infect
less
expens
routin
strategi
use
dfa
andor
cultur
cost
analysi
reveal
averag
diagnost
cost
per
pediatr
inpati
lowest
strategi
use
xtag
rvp
test
alon
compar
dfa
alon
dfa
plu
cultur
dfa
plu
rvp
assay
four
diagnost
strategi
compar
rvp
alon
least
costli
strategi
preval
infect
higher
dfa
alon
less
costli
preval
less
estim
save
cad
per
case
xtag
rvp
test
alon
use
replac
dfa
plu
cultur
save
cad
per
year
direct
cost
four
hospit
includ
studi
oper
workflow
analysi
use
lean
methodolog
principl
employ
anoth
studi
evalu
potenti
advantag
multiplex
beadbas
array
laboratori
workflow
associ
cost
implement
rvp
assay
result
standard
workflow
decreas
laboratori
cost
improv
effici
compar
dfa
cultur
diagnosi
respiratori
virus
workflow
evalu
term
total
handson
time
number
oper
step
hospit
laboratori
cost
associ
test
calcul
test
posit
neg
result
scenario
combin
score
sampl
includ
analysi
reveal
handson
time
complet
sampl
h
rvp
compar
h
dfa
cultur
total
cost
per
sampl
unit
state
dollar
usd
dfaposit
sampl
cultur
addit
test
perform
rang
usd
dfaneg
sampl
reflex
cultur
variabl
time
complet
total
cost
rvp
usd
regardless
result
although
rvp
requir
time
step
slightli
expens
per
test
dfa
screen
alon
sampl
popul
studi
dfaposit
addit
time
cost
associ
followup
cultur
larg
percentag
dfaneg
specimen
far
greater
thu
beadbas
array
assay
provid
increas
diagnost
capabl
respiratori
viral
infect
also
maxim
effici
reduc
cost
associ
diagnosi
recent
advanc
molecular
diagnost
provid
clinic
laboratori
new
method
allow
rapid
diagnosi
treatment
infecti
diseas
among
multiplex
beadbas
suspens
array
emerg
rapid
highthroughput
costeffect
mean
provid
physician
reliabl
action
result
time
improv
patient
care
particular
beadbas
suspens
array
assay
demonstr
method
choic
comprehens
detect
identif
respiratori
virus
improv
diagnosi
allow
identif
coinfect
provid
valuabl
epidemiolog
data
aid
respons
outbreak
respiratori
infect
avail
assay
clear
ivd
use
technolog
becom
easi
implement
even
diagnost
laboratori
limit
experi
molecular
techniqu
anticip
new
assay
develop
exist
assay
continu
enhanc
improv
simpler
protocol
streamlin
workflow
autom
assay
continu
prove
valuabl
diagnosi
respiratori
virus
infecti
diseas
